Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1986 Apr;203(4):420–425. doi: 10.1097/00000658-198604000-00014

Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease.

W J Hodgson, M Friedland, T Ahmed, A Mittelman, H Berman, S Katz, J Morgan, D Byrne
PMCID: PMC1251128  PMID: 2938551

Abstract

Because of the wide variation in reported benefits from the use of intrahepatic chemotherapy for colorectal hepatic metastases, the authors performed their own phase II studies comparing the use of intrahepatic chemotherapy alone and intrahepatic chemotherapy as an adjuvant to complete or partial removal of metastatic colorectal cancer to the liver. Techniques for partial removal included unilateral and bilateral wedge resection, peripheral presinusoidal embolization of the liver, and portal vein branch ligation. Patients were staged using the per cent hepatic replacement method of Pettavel and Taylor, and patients with bilateral metastases were included in the study. Twenty-seven patients, mean age 60.3 years, were examined. There were 19 males, mean age 60.4 years, and eight females, mean age 60 years. The patients were divided into four groups. Group A had an implantable pump only; Group B had an implantable pump and resection; Group C had an implantable pump and arterial embolization and portal vein branch ligation; and Group D had an implantable pump, partial resection, arterial embolization, and portal vein branch ligation. Kaplan-Meyer survival curves were calculated for all of these groups. A separate analysis was carried out for each of the stages, and a comparison was made. The study indicated that the overall median survival time was 18 months and that the more radical the treatment in addition to chemotherapy, the better the results. Such results were not totally dependent on the staging of the tumor volume but were dependent on the degree of extirpation of the tumor. In Group C, consisting primarily of Stage IIa, IIIa, and IV patients (i.e., unresectable patients), a doubling of expected median survival to 12 months could be achieved, compared to those in Group A, which achieved a median survival of only 6 months.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balch C. M., Urist M. M., Soong S. J., McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg. 1983 Nov;198(5):567–573. doi: 10.1097/00000658-198311000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bengmark S., Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer. 1969 Jan;23(1):198–202. doi: 10.1002/1097-0142(196901)23:1<198::aid-cncr2820230126>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  3. Chuang V. P., Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology. 1981 Jul;140(1):51–58. doi: 10.1148/radiology.140.1.7244243. [DOI] [PubMed] [Google Scholar]
  4. Cohen A. M., Greenfield A., Wood W. C., Waltman A., Novelline R., Athanasoulis C., Schaeffer N. J. Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer. 1983 Jun 1;51(11):2013–2019. doi: 10.1002/1097-0142(19830601)51:11<2013::aid-cncr2820511109>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  5. Daly J. M., Kemeny N., Oderman P., Botet J. Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg. 1984 Aug;119(8):936–941. doi: 10.1001/archsurg.1984.01390200054013. [DOI] [PubMed] [Google Scholar]
  6. Fischerman K., Petersen C. F., Jensen S. L., Christensen K. C., Efsen F. Survival among patients with liver metastases from cancer of the colon and rectum. Scand J Gastroenterol Suppl. 1976;37:111–115. [PubMed] [Google Scholar]
  7. Grage T. B., Vassilopoulos P. P., Shingleton W. W., Jubert A. V., Elias E. G., Aust J. B., Moss S. E. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery. 1979 Oct;86(4):550–555. [PubMed] [Google Scholar]
  8. Hodgson W. J., DelGuercio L. R. Preliminary experience in liver surgery using the ultrasonic scalpel. Surgery. 1984 Feb;95(2):230–234. [PubMed] [Google Scholar]
  9. Honjo I., Suzuki T., Ozawa K., Takasan H., Kitamura O. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg. 1975 Sep;130(3):296–302. doi: 10.1016/0002-9610(75)90389-x. [DOI] [PubMed] [Google Scholar]
  10. Jaffe B. M., Donegan W. L., Watson F., Spratt J. S., Jr Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet. 1968 Jul;127(1):1–11. [PubMed] [Google Scholar]
  11. Johnson L. P., Rivkin S. E. The implanted pump in metastatic colorectal cancer of the liver. Risk versus benefit. Am J Surg. 1985 May;149(5):595–598. doi: 10.1016/s0002-9610(85)80133-1. [DOI] [PubMed] [Google Scholar]
  12. Moertel C. G. Chemotherapy of gastrointestinal cancer. N Engl J Med. 1978 Nov 9;299(19):1049–1052. doi: 10.1056/NEJM197811092991906. [DOI] [PubMed] [Google Scholar]
  13. Nielsen J., Balslev I., Jensen H. E. Carcinoma of the colon with liver metastases. Operative indications and prognosis. Acta Chir Scand. 1971;137(5):463–465. [PubMed] [Google Scholar]
  14. PESTANA C., REITEMEIER R. J., MOERTEL C. G., JUDD E. S., DOCKERTY M. B. THE NATURAL HISTORY OF CARCINOMA OF THE COLON AND RECTUM. Am J Surg. 1964 Dec;108:826–829. doi: 10.1016/0002-9610(64)90041-8. [DOI] [PubMed] [Google Scholar]
  15. Pettavel J., Morgenthaler F. Protracted arterial chemotherapy of liver tumors: an experience of 107 cases over a 12-year period. Prog Clin Cancer. 1978;7:217–233. [PubMed] [Google Scholar]
  16. Reed M. L., Vaitkevicius V. K., Al-Sarraf M., Vaughn C. B., Singhakowinta A., Sexon-Porte M., Izbicki R., Baker L., Straatsma G. W. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer. 1981 Jan 15;47(2):402–409. doi: 10.1002/1097-0142(19810115)47:2<402::aid-cncr2820470231>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  17. SULLIVAN R. D., NORCROSS J. W., WATKINS E., Jr CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION. N Engl J Med. 1964 Feb 13;270:321–327. doi: 10.1056/NEJM196402132700701. [DOI] [PubMed] [Google Scholar]
  18. Taylor I. Studies on the treatment and prevention of colorectal liver metastases. Ann R Coll Surg Engl. 1981 Jul;63(4):270–276. [PMC free article] [PubMed] [Google Scholar]
  19. Wanebo H. J., Semoglou C., Attiyeh F., Stearns M. J., Jr Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg. 1978 Jan;135(1):81–85. doi: 10.1016/0002-9610(78)90014-4. [DOI] [PubMed] [Google Scholar]
  20. Welch J. P., Donaldson G. A. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg. 1979 Apr;189(4):496–502. doi: 10.1097/00000658-197904000-00027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wood C. B., Gillis C. R., Blumgart L. H. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976 Sep;2(3):285–288. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES